Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 22, 2021 10:00 ET | Source: Alladapt Immunotherapeutics

Alladapt Commences Phase 1/2 Clinical Trial in Food Allergy

− Harmony Study began dosing patients who are allergic to one food or to multiple foods in a Phase 1/2 clinical trial – − ADP101 is an investigational oral immunotherapy product candidate...